Antimicrobial Activity of Some New Thioureides Derived from 2-(4-Chlorophenoxymethyl)benzoic Acid

Abstract

We report here the characterisation of eight newly synthesized thioureides of 2-(4-chlorophenoxymethyl)-benzoic acid and the evaluation of the in vitro antimicrobial activity of the new compounds against Gram-positive [Listeria monocytogenes, Staphylococcus aureus, Bacillus subtilis], Gram-negative [Psedomonas aeruginosa, Escherichia coli, Salmonella enteritidis], as well as Candida spp., using both reference and clinical multidrug resistant strains to establish the minimal inhibitory concentration (MIC) values. Our results showed that the tested compounds exhibited specific antimicrobial activities, both concerning the spectrum of antimicrobial activity and the corresponding MIC values, which ranged widely between 1024 and 32 μg/mL, depending on the nature and position of the substituents on the benzene ring. The most active compounds were N-[2-(4-chlorophenoxymethyl)-benzoyl]-N'-(2,6-dichlorophenyl)-thiourea (5g) and N-[2-(4-chlorophenoxymethyl)-benzoyl]-N'-(4-bromophenyl)-thiourea (5h), which showed a broad spectrum of antimicrobial activity against enterobacterial strains (E. coli and S. enteritidis), P. aeruginosa, S. aureus and Candida spp. All the tested compounds except 5f were highly active against S. aureus (MIC=32 μg/mL), suggesting their possible use in the treatment of MRSA infections. Four of compounds also exhibited antifungal activity (MIC =256-32 μg/mL) against C. albicans, but L. monocytogenes as well as B. subtilis were resistant to all tested compounds. Our studies thus demonstrated that among other biological activities, the thioureides of 2-(4-chlorophenoxymethyl)-benzoic acid also exhibit selective and effective antimicrobial properties that could lead to the selection and use of these compounds as efficient antimicrobial agents, especially for the treatment of multidrug resistant infections.

Introduction

Thioureides are associated with a broad spectrum of biological activities including antibacterial, antifungal, tuberculostatic, anthelmintic, antitumor, anticonvulsant, diuretic, insecticidal and pesticidal properties. In light of the therapeutical importance of some N-acylated thiourea derivates, especially as antibacterials and antifungals, we have evaluated the in vitro activity of some new thioureides derived from 2-(4-chlorophenoxymethyl)-benzoic acid. We have focused on a qualitative screening assay of the antimicrobial properties (adapted disk diffusion method), as well as a quantitative assay of the antimicrobial activity (binary microdilution method), to establish the minimal inhibitory concentration (MIC) values of these compounds against microbial Gram-positive, Gram-negative and fungal strains. We also studied the cytototoxicity of the tested compounds by flow cytometry and annexin V assay. In previous papers [1,2,3,4] we have presented the synthesis and characterization of some other thioureides of 2-phenoxymethylbenzoic acid, either unsubstituted or substituted with a methoxy or methyl group. We have now extended our research to the preparation and evaluation of the antimicrobial activity of some new thioureides of 2-(4-chlorophenoxymethyl)-benzoic acid. The reaction conditions, yields and some of the physical properties were established. NMR and IR spectral parameters and the elemental analysis have confirmed the structure of the synthesized compounds.

Results and Discussion

Synthesis

The synthesis of the new compounds was completed in three stages:

I. The synthesis of 2-(4-chlorophenoxymethyl)-benzoic acid (1)

The best yields in the synthesis of compound 1 were obtained when the intermediate compound used was the phthalide 2, which was treated with potassium p-chlorophenoxide in xylene under reflux.

This gives the potassium salt 3 of 2-(4-chlorophenoxymethyl)-benzoic acid, which has good solubility in 10% aqueous sodium hydroxide solution, allowing its facile separation from xylene. The acid 1 is then precipitated using a mineral acid solution. The potassium p-chlorophenoxide was obtained through the reaction of p-chlorophenol with potassium hydroxide in xylene. The resulting water was removed by azeotropic distillation. These reactions are presented in Scheme 1.

Scheme 1. The synthesis of 2-(4-chlorophenoxymethyl)-benzoic acid (1).

Scheme 1. The synthesis of 2-(4-chlorophenoxymethyl)-benzoic acid (1).

II. The synthesis of 2-(4-chloro-phenoxymethyl)-benzoyl chloride (4)

2-(4-Chlorophenoxymethyl)-benzoyl chloride (4) was prepared by refluxing acid 1 with thionyl chloride, using anhydrous 1,2-dichlorethane as reaction medium (Scheme 2).

Scheme 2. The synthesis of 2-(4-chlorophenoxymethyl)-benzoyl chloride (4).

Scheme 2. The synthesis of 2-(4-chlorophenoxymethyl)-benzoyl chloride (4).

III. The synthesis of the new thioureides 5a-h

The new compounds 5a-h were prepared by refluxing 2-(4-chlorophenoxymethyl)-benzoyl isothiocyanate (6) with primary aromatic amines in dry acetone. The isothiocyanate 6 was obtained through the reaction between 2-(4-chlorophenoxymethyl)-benzoyl chloride (4) and ammonium thiocyanate in dry acetone, as shown in Scheme 3. The isothiocyanate was not isolated and the appropriate amines were directly added to the reaction mixture to give the thioureides.

Figure 3. The synthesis of the new thioureides 5a-h.

Figure 3. The synthesis of the new thioureides 5a-h.

The new thioureides are white or light yellow crystalline solids, soluble at room temperature in acetone and chloroform, by heating in lower alcohols, benzene, toluene and xylene and insoluble in water. The structure, molecular formulae, molecular weights, melting points and yields of the new thioureides are presented in Table 1.

Table 1. Characteristics of the new compounds.

No.	R	Molecular formula	Molecular weight	Melting point (0C)	Yield (%)
5a	-C6H5	C21H17ClN2O2S	396.893	145.2- 147.6	64.3
5b	-C6H4CH3 (4)	C22H19Cl N2O2S	410.913	135.7- 138.1	62.9
5c	-C6H4OCH3 (4)	C22H19ClN2O3S	426.913	132.3- 135.4	69.4
5d	-C6H4Cl (4)	C21H16Cl2N2O2S	431.336	154.8- 157.4	73.2
5e	-C6H3Cl2 (2,4)	C21H15Cl3N2O2S	465.786	152.5- 155.0	71.6
5f	-C6H3Cl2 (2,5)	C21H15Cl3N2O2S	465.786	152.6- 155.2	78.5
5g	-C6H3Cl2 (2,6)	C21H15Cl3N2O2S	465.786	201.9- 204.6	65.7
5h	-C6H4Br (4)	C21H16ClBrN2O2S	475.799	163.5- 165.2	75.3

Table 1. Characteristics of the new compounds.

No.	R	Molecular formula	Molecular weight	Melting point (0C)	Yield (%)
5a	-C6H5	C21H17ClN2O2S	396.893	145.2- 147.6	64.3
5b	-C6H4CH3 (4)	C22H19Cl N2O2S	410.913	135.7- 138.1	62.9
5c	-C6H4OCH3 (4)	C22H19ClN2O3S	426.913	132.3- 135.4	69.4
5d	-C6H4Cl (4)	C21H16Cl2N2O2S	431.336	154.8- 157.4	73.2
5e	-C6H3Cl2 (2,4)	C21H15Cl3N2O2S	465.786	152.5- 155.0	71.6
5f	-C6H3Cl2 (2,5)	C21H15Cl3N2O2S	465.786	152.6- 155.2	78.5
5g	-C6H3Cl2 (2,6)	C21H15Cl3N2O2S	465.786	201.9- 204.6	65.7
5h	-C6H4Br (4)	C21H16ClBrN2O2S	475.799	163.5- 165.2	75.3

The calculated formulae for the proposed structures were in good agreement with the elemental analysis results (Table 2).

Table 2. Elemental analysis data.

No.	R	C%		H%		N%		S%
		c.	e.	c.	e.	c.	e.	c.	e.
5a.	-C6H5	63.49	63.36	4.28	4.25	7.05	6.99	8.06	7.94
5b.	-C6H4CH3 (4)	64.24	63.99	4.62	4.60	6.81	6.78	7.78	7.82
5c.	-C6H4OCH3 (4)	61.83	61.64	4.45	4.49	6.56	6.45	7.49	7.54
5d.	-C6H4Cl (4)	58,42	58.70	3.70	3.70	6.49	6.37	7.42	7.41
5e.	-C6H3Cl2 (2,4)	54.10	54.20	3.22	3.24	6.01	5.97	6.87	6.70
5f.	-C6H3Cl2 (2,5)	54.10	54.03	3.22	3.29	6.01	5.92	6.87	6.71
5g.	-C6H3Cl2 (2,6)	54.10	54.09	3.22	3.18	6.01	5.99	6.87	6.82
5h.	-C6H4Br (4)	52.96	52.64	3.36	3.29	5.88	5.76	6.72	6.65

c = calculated; e = experimental

Table 2. Elemental analysis data.

No.	R	C%		H%		N%		S%
		c.	e.	c.	e.	c.	e.	c.	e.
5a.	-C6H5	63.49	63.36	4.28	4.25	7.05	6.99	8.06	7.94
5b.	-C6H4CH3 (4)	64.24	63.99	4.62	4.60	6.81	6.78	7.78	7.82
5c.	-C6H4OCH3 (4)	61.83	61.64	4.45	4.49	6.56	6.45	7.49	7.54
5d.	-C6H4Cl (4)	58,42	58.70	3.70	3.70	6.49	6.37	7.42	7.41
5e.	-C6H3Cl2 (2,4)	54.10	54.20	3.22	3.24	6.01	5.97	6.87	6.70
5f.	-C6H3Cl2 (2,5)	54.10	54.03	3.22	3.29	6.01	5.92	6.87	6.71
5g.	-C6H3Cl2 (2,6)	54.10	54.09	3.22	3.18	6.01	5.99	6.87	6.82
5h.	-C6H4Br (4)	52.96	52.64	3.36	3.29	5.88	5.76	6.72	6.65

c = calculated; e = experimental

Spectral data

All new compounds were characterized by ¹H- and ¹³C-NMR and IR spectroscopy. The ¹H-NMR spectral values (δ, ppm, J, Hz) for the new compounds are presented in Table 3. In Table 4, we present the ¹³C-NMR assigments for the new thioureides. The caracteristic IR bands (cm^-1) for the 2-(4-chloro-phenoxymethyl)-benzoic acid thioureides are presented in Table 5.

Table 3. ¹H-NMR data (δ, ppm, J, Hz).

R	H4- H7	H8	H10	H11	H13	H14	H17	H18	H19	H20	H21	-NH-	-CH3
														-OCH3
	7.28- 7.68 m	5.32 s	7.01 d (7.9)	7.30 d (7.9)	7.30 d (7.9)	7.01 d (7.9)	7.28- 7.68 m	7.28- 7.68 m	7.28- 7.68 m	7.28- 7.68 m	7.28- 7.68 m	11.84 s 12.40 s	-
	7.56- 7.62 m	5.30 s	7.31 d (8.9)	7.00 d (9.0)	7.00 d (9.0)	7.31 d (8.9)	7.45 d (8.6)	7.20 d (8.2)	-	7.20 d (8.2)	7.45 d (8.6)	11.79 s l12.33 sl	2.30 s
	7.45- 7.66 m	5.31 s	7.02 d (8.9)	7.46 d (9.0)	7.46 d (9.0)	7.02 d (8.9)	7.32 d (8.8)	6.96 d (8.8)	-	6.96 d (8.8)	7.32 d (8.8)	11.79 s 12.26 s
														3.77 s
	7.42- 7.63 m	5.32 s	7.00 d (9.0)	7.30 d (9.0)	7.30 d (9.0)	7.00 d (9.0)	7.46 d (8.8)	7.62 d (8.8)	-	7.62 d (8.8)	7.46 d (8.8)	11.90 s 12.38 s	-
	7.42- 7.68 m	5.30 s	6.99 d (9.1)	7.30 d (9.1)	7.30 d (9.1)	6.99 d (9.1)	-	7.73 d (2.3)	-	7.81 dd (8.8; 2.3)	7.96 d (8.8)	12.12 s 12.43 s	-
	7.40- 7.70m	5.30 s	7.01 d (8.9)	7.28 d (8.9)	7.28 d (8.9)	7.01 d (8.9)	-	7.40-7.70 m	7.39 dd (8.9; 2.6)	-	8.11 d (2.6)	12.16 s 12.53 s	-
	7.42-7.62 m	5.28 s	7.00 d (8.9)	7.32 d (8.9)	7.32 d (8.9)	7.00 d (8.9)	-	7.54 d (8.0)	7.37 dd (8.0; 7.4)	7.54 d (8.0)	-	11.05 s 11.39 s	-
	7.45- 7.70 m	5.34 s	7.00 d (8.9)	7.31 d (8.9)	7.31 d (8.9)	7.00 d (8.9)	7.57 s	7.57 s	-	7.57 s	7.57 s	11.89 s 12.37 s	-

Table 3. ¹H-NMR data (δ, ppm, J, Hz).

R	H4- H7	H8	H10	H11	H13	H14	H17	H18	H19	H20	H21	-NH-	-CH3
														-OCH3
	7.28- 7.68 m	5.32 s	7.01 d (7.9)	7.30 d (7.9)	7.30 d (7.9)	7.01 d (7.9)	7.28- 7.68 m	7.28- 7.68 m	7.28- 7.68 m	7.28- 7.68 m	7.28- 7.68 m	11.84 s 12.40 s	-
	7.56- 7.62 m	5.30 s	7.31 d (8.9)	7.00 d (9.0)	7.00 d (9.0)	7.31 d (8.9)	7.45 d (8.6)	7.20 d (8.2)	-	7.20 d (8.2)	7.45 d (8.6)	11.79 s l12.33 sl	2.30 s
	7.45- 7.66 m	5.31 s	7.02 d (8.9)	7.46 d (9.0)	7.46 d (9.0)	7.02 d (8.9)	7.32 d (8.8)	6.96 d (8.8)	-	6.96 d (8.8)	7.32 d (8.8)	11.79 s 12.26 s
														3.77 s
	7.42- 7.63 m	5.32 s	7.00 d (9.0)	7.30 d (9.0)	7.30 d (9.0)	7.00 d (9.0)	7.46 d (8.8)	7.62 d (8.8)	-	7.62 d (8.8)	7.46 d (8.8)	11.90 s 12.38 s	-
	7.42- 7.68 m	5.30 s	6.99 d (9.1)	7.30 d (9.1)	7.30 d (9.1)	6.99 d (9.1)	-	7.73 d (2.3)	-	7.81 dd (8.8; 2.3)	7.96 d (8.8)	12.12 s 12.43 s	-
	7.40- 7.70m	5.30 s	7.01 d (8.9)	7.28 d (8.9)	7.28 d (8.9)	7.01 d (8.9)	-	7.40-7.70 m	7.39 dd (8.9; 2.6)	-	8.11 d (2.6)	12.16 s 12.53 s	-
	7.42-7.62 m	5.28 s	7.00 d (8.9)	7.32 d (8.9)	7.32 d (8.9)	7.00 d (8.9)	-	7.54 d (8.0)	7.37 dd (8.0; 7.4)	7.54 d (8.0)	-	11.05 s 11.39 s	-
	7.45- 7.70 m	5.34 s	7.00 d (8.9)	7.31 d (8.9)	7.31 d (8.9)	7.00 d (8.9)	7.57 s	7.57 s	-	7.57 s	7.57 s	11.89 s 12.37 s	-

Table 4. ¹³C-NMR data (δ, ppm).

R
C1		169.57	170.05		170.02		169.98
C2		134.99	131.04		133.37		131.1
C3		137.64	135.64		135.24		136.8
C4		127.56	124.19		127.9		126.1
C5		133.10	129.22		131.05		133.3
C6		128.26	128.41		128.56		127.9
C7		128.17	127.88		128.44		127.9
C8		67.73	67.79		67.8		67,82
C9		156.83	157.0		157.05		157.03
C10		116.37	116.44		116.50		116,49
C11		130.73	129.05		129.25		129.3
C12		125,9	124.68		125.9		128.5
C13		130.73	129.05		129.25		129.3
C14		116.37	116.44		116.50		116,49
C15		178.65	178.83		179.05		179.18
C16		134.9	135.22		130.7		135.3
C17		123.77	124.09		124.74		124.7
C18		128.88	128.55		113.78		128.4
C19		124.58	133.32		157.44		130.2
C20		128.88	128.55		113.78		128.4
C21		123.77	124.09		124.74		124.7
-CH3		-	20.60				-
	-OCH3					55.30
R
C1		170.11	170.32		169.50		169.98
C2		133.29	131.19		133.14		133.23
C3		135.33	135.25		134.93		137.25
C4		128.56	128.05		128.18		127.90
C5		131.37	131.10		130.86		131.46
C6		128.76	128.69		128.29		128.58
C7		128.69	128.65		128.69		128.44
C8		68.13	67.94		67.79		67.80
C9		157.13	157.01		156.83		157.02
C10		116.66	116.41		116.45		116.48
C11		129.26	129.20		128.9		129.24
C12		127.95	127.71		127.78		126.41
C13		129.26	129.20		128.9		129.24
C14		116.66	116.41		116.45		116.48
C15		180.12	179.95		180.51		179.10
C16		134.60	136.5		133.53		135.3
C17		128.91	126.88		127.88		124.73
C18		129.17	130.78		129.46		131.13
C19		131.14	126.99		128.18		118.49
C20		127.27	133.22		129.46		131.13
C21		124.93	124.74		124.58		124.73
-CH3		-	-		-		-
	-OCH3

Table 4. ¹³C-NMR data (δ, ppm).

R
C1		169.57	170.05		170.02		169.98
C2		134.99	131.04		133.37		131.1
C3		137.64	135.64		135.24		136.8
C4		127.56	124.19		127.9		126.1
C5		133.10	129.22		131.05		133.3
C6		128.26	128.41		128.56		127.9
C7		128.17	127.88		128.44		127.9
C8		67.73	67.79		67.8		67,82
C9		156.83	157.0		157.05		157.03
C10		116.37	116.44		116.50		116,49
C11		130.73	129.05		129.25		129.3
C12		125,9	124.68		125.9		128.5
C13		130.73	129.05		129.25		129.3
C14		116.37	116.44		116.50		116,49
C15		178.65	178.83		179.05		179.18
C16		134.9	135.22		130.7		135.3
C17		123.77	124.09		124.74		124.7
C18		128.88	128.55		113.78		128.4
C19		124.58	133.32		157.44		130.2
C20		128.88	128.55		113.78		128.4
C21		123.77	124.09		124.74		124.7
-CH3		-	20.60				-
	-OCH3					55.30
R
C1		170.11	170.32		169.50		169.98
C2		133.29	131.19		133.14		133.23
C3		135.33	135.25		134.93		137.25
C4		128.56	128.05		128.18		127.90
C5		131.37	131.10		130.86		131.46
C6		128.76	128.69		128.29		128.58
C7		128.69	128.65		128.69		128.44
C8		68.13	67.94		67.79		67.80
C9		157.13	157.01		156.83		157.02
C10		116.66	116.41		116.45		116.48
C11		129.26	129.20		128.9		129.24
C12		127.95	127.71		127.78		126.41
C13		129.26	129.20		128.9		129.24
C14		116.66	116.41		116.45		116.48
C15		180.12	179.95		180.51		179.10
C16		134.60	136.5		133.53		135.3
C17		128.91	126.88		127.88		124.73
C18		129.17	130.78		129.46		131.13
C19		131.14	126.99		128.18		118.49
C20		127.27	133.22		129.46		131.13
C21		124.93	124.74		124.58		124.73
-CH3		-	-		-		-
	-OCH3

Table 5. IR data for the new compounds.

R	-CH2-O-					-CO-NH-
	ν CH2sym	ν CH2 asym	νC-O-Csym	νC-O-Casym	δ CH2	ν C-N
-C6H5	2852.2	2921.7	1008.2	1243.0	1491.4	1553.6	1243.0
-C6H4CH3 (4)	2852.2	2921.7	1012.7	1243.9	1491.1	1550.6	1243.9
-C6H4OCH3 (4)	2829.0	2910.1	1036.6	1241.1	1488.5	1553.1	1241.1
-C6H4Cl (4)	2848.3	2929.4	1035.1	1243.1	1491.3	1554.3	1243.1
-C6H3Cl2 (2,4)	2856.0	2921.7	1036.0	1242.7	1491.5	1540.0	1242.7
-C6H3Cl2 (2,5)	2852.2	2921.7	1036.3	1243.6	1491.0	1552.7	1243.6
-C6H3Cl2 (2,6)	2856.0	2917.8	1036.5	1240.3	1486.9	1553.3	1240.3
-C6H4Br (4)	2852.2	2921.7	1033.4	1242.9	1490.5	1553.9	1242.9
R	-CO-NH-		aromatic rings		-NH-CS-NH-	C-halogen
	ν C=O	ν N-H	ν =CH	ν C=C	ν C=S	ν C-Cl	ν C-Br
-C6H5	1682.9	3442.7	3018.1	1598.7	1166.7	749.5	-
-C6H4CH3 (4)	1683.5	3458.1	3029.7	1596.8	1164.0	749.1	-
-C6H4OCH3 (4)	1683.4	3436.9	3002.7	1598.6	1167.4	746.7	-
-C6H4Cl (4)	1679.8	3356.4	3029.7	1603.2	1151.4	744.2	-
-C6H3Cl2 (2,4)	1684.0	3381.1	3099.2	1584.2	1152.9	744.8	-
-C6H3Cl2 (2,5)	1679.1	3442.7	3025.9	1585.0	1168.2	751.6	-
-C6H3Cl2 (2,6)	1693.1	3439.4	3030.2	1597.8	1168.3	753.2	-
-C6H4Br (4)	1678.6	3360.7	3030.6	1600.7	1151.1	755.9	607.7

Table 5. IR data for the new compounds.

R	-CH2-O-					-CO-NH-
	ν CH2sym	ν CH2 asym	νC-O-Csym	νC-O-Casym	δ CH2	ν C-N
-C6H5	2852.2	2921.7	1008.2	1243.0	1491.4	1553.6	1243.0
-C6H4CH3 (4)	2852.2	2921.7	1012.7	1243.9	1491.1	1550.6	1243.9
-C6H4OCH3 (4)	2829.0	2910.1	1036.6	1241.1	1488.5	1553.1	1241.1
-C6H4Cl (4)	2848.3	2929.4	1035.1	1243.1	1491.3	1554.3	1243.1
-C6H3Cl2 (2,4)	2856.0	2921.7	1036.0	1242.7	1491.5	1540.0	1242.7
-C6H3Cl2 (2,5)	2852.2	2921.7	1036.3	1243.6	1491.0	1552.7	1243.6
-C6H3Cl2 (2,6)	2856.0	2917.8	1036.5	1240.3	1486.9	1553.3	1240.3
-C6H4Br (4)	2852.2	2921.7	1033.4	1242.9	1490.5	1553.9	1242.9
R	-CO-NH-		aromatic rings		-NH-CS-NH-	C-halogen
	ν C=O	ν N-H	ν =CH	ν C=C	ν C=S	ν C-Cl	ν C-Br
-C6H5	1682.9	3442.7	3018.1	1598.7	1166.7	749.5	-
-C6H4CH3 (4)	1683.5	3458.1	3029.7	1596.8	1164.0	749.1	-
-C6H4OCH3 (4)	1683.4	3436.9	3002.7	1598.6	1167.4	746.7	-
-C6H4Cl (4)	1679.8	3356.4	3029.7	1603.2	1151.4	744.2	-
-C6H3Cl2 (2,4)	1684.0	3381.1	3099.2	1584.2	1152.9	744.8	-
-C6H3Cl2 (2,5)	1679.1	3442.7	3025.9	1585.0	1168.2	751.6	-
-C6H3Cl2 (2,6)	1693.1	3439.4	3030.2	1597.8	1168.3	753.2	-
-C6H4Br (4)	1678.6	3360.7	3030.6	1600.7	1151.1	755.9	607.7

Qualitative antimicrobial activity screening

The qualitative method used for the screening of the antimicrobial activity for all tested compounds was an adaptation of the disk diffusion method (see Figure 1). The results correlated well with those of the quantitative antimicrobial activity assays.

Figure 1. The aspect of inhibition zones obtained for the tested compounds on different pathogens in the qualitative screening assay by the adapted Kirby- Bauer method.

Figure 1. The aspect of inhibition zones obtained for the tested compounds on different pathogens in the qualitative screening assay by the adapted Kirby- Bauer method.

Quantitative antimicrobial activity assay

The quantitative assay results for the antimicrobial activity of the new thioureides are presented in Table 6. These results show that the tested compounds exhibited a specific antimicrobial activity, depending on the nature of the substituents and their position on the benzene ring, both concerning the microbial spectrum and the MIC values, which ranged widely between 1024 and 32 μg/mL. The most active compounds proved to be N-[2-(4-chlorophenoxymethyl)-benzoyl]-N'-(2,6-dichlorophenyl)-thiourea (5g) and N-[2-(4-chlorophenoxymethyl)-benzoyl]-N'-(4-bromophenyl)-thiourea (5h), which showed a broad spectrum of antimicrobial activity against enterobacterial strains (E. coli and S. enteritidis), P. aeruginosa, S. aureus and Candida spp. All the tested compounds were highly active against S. aureus (MIC= 32 μg/mL), suggesting their possible use in the treatment of MRSA infections. Four of the tested compounds exhibited antifungal activity (MIC= 256-32 μg/mL), and L. monocitogenes as well as B. subtilis were resistant to all tested compounds.

Table 6. The quantitative antibacterial and antifungal activity test results of the new thioureides and the respective MIC values.

Organisms	Compounds
	5a	5b	5c	5d	5e	5f	5g	5h
E. coli	> 1024	32	32	32	> 1024	> 1024	256	128
S. enteritidis	256	> 1024	> 1024	32	> 1024	> 1024	128	128
P. aeruginosa	> 1024	> 1024	> 1024	> 1024	> 1024	> 1024	32	32
L. monocytogenes	> 1024	> 1024	> 1024	> 1024	512	512	> 1024	> 1024
S. aureus	32	32	32	32	32	256	32	32
B. subtilis	> 1024	> 1024	1024	> 1024	> 1024	> 1024	> 1024	> 1024
C. albicans	256	64	512	512	> 1024	> 1024	32	32

Table 6. The quantitative antibacterial and antifungal activity test results of the new thioureides and the respective MIC values.

Organisms	Compounds
	5a	5b	5c	5d	5e	5f	5g	5h
E. coli	> 1024	32	32	32	> 1024	> 1024	256	128
S. enteritidis	256	> 1024	> 1024	32	> 1024	> 1024	128	128
P. aeruginosa	> 1024	> 1024	> 1024	> 1024	> 1024	> 1024	32	32
L. monocytogenes	> 1024	> 1024	> 1024	> 1024	512	512	> 1024	> 1024
S. aureus	32	32	32	32	32	256	32	32
B. subtilis	> 1024	> 1024	1024	> 1024	> 1024	> 1024	> 1024	> 1024
C. albicans	256	64	512	512	> 1024	> 1024	32	32

Flow cytometry and annexin V assay

The cytotoxicity of the most active antimicrobial compounds, 5g and 5h, was tested with their possible use in much more in depth studies for the design of new antimicrobial chemical compounds in mind.

Table 7. Cytotoxic effects of the 5g and 5h on HeLa cells quantified by flow cytometry assay.

	HeLa cells
	1 (% necrosis)	2 (% secondary necrosis)	3 (% viable cells)	4 (% apoptosis)
Cell control	3.42	0.70	95.00	0.19
5g	13.89	9.10	84.00	0.15
5h	6.77	0.70	95.00	0.15

Table 7. Cytotoxic effects of the 5g and 5h on HeLa cells quantified by flow cytometry assay.

	HeLa cells
	1 (% necrosis)	2 (% secondary necrosis)	3 (% viable cells)	4 (% apoptosis)
Cell control	3.42	0.70	95.00	0.19
5g	13.89	9.10	84.00	0.15
5h	6.77	0.70	95.00	0.15

The cytotoxicity assay has demonstrated that the two selected compounds exhibited low cytotoxicity levels, comparable to those obtained for the cell control (Table 7, Figure 2), demonstrating the possibility to be configured for the in vivo antimicrobial use.

Figure 2. Flow cytometry dot-plots of effects on HeLa cells: a) Control; b) 5g; c) 5h.

Figure 2. Flow cytometry dot-plots of effects on HeLa cells: a) Control; b) 5g; c) 5h.

Conclusions

In summary, our studies have demonstrated that among other biological activities, the thioureides of 2-(4-chlorophenoxymethyl)-benzoic acid also exhibit selective and effective antimicrobial properties that could lead to the selection and use of these compounds as efficient antimicrobial agents, especially for the treatment of multidrug resistant infections.

Experimental

General

The new compounds were prepared in three steps, as described above, and their physical properties and chemical structures further characterized and confirmed by elemental analysis, ¹H-NMR, ¹³C-NMR and IR. All melting points were recorded with an Electrothermal 9100 apparatus and are uncorrected. Elemental analysis was realized using a Perkin Elmer CHNS/O Analyser Series II 2400 apparatus. The NMR spectra were recorded on a Gemini 300BB instrument, operating at 300 MHz for ¹H and 75 MHz for ¹³C, using solutions in DMSO-d₆ as solvent and tetramethylsilane as internal reference. The IR spectra were recorded using potassium bromide tablets on a Biorad FTS 135 apparatus.

Synthesis of 2-(4-chloro-phenoxymethyl)-benzoic acid (1)

A solution of freshly distilled p-chlorophenol (mol. wt. 128.61, 6.43 g, 0.05 mol) in xylene (30 mL) was placed in a round-bottomed flask equipped with a Dean-Stark trap device, then Subsequently, potassium hydroxide (mol. wt. 56.11, 3.10 g, 0.055 mol) was added. The reaction mixture was refluxed while the resulting water was removed by azeotropic distillation and potassium p-chloro-phenoxide precipitated. Phthalide (mol. wt. 134.14, 6.7 g, 0.05 mol) was added and the mixture was refluxed until it solidified. The precipitate was heated with 10% potassium hydroxide solution until id dissolved and it then was diluted with water. The aqueous phase was separated and acidulated (pH= 3) with 1M hydrochloric acid solution, whereupon the 2-(4-chlorophenoxymethyl)-benzoic acid (mol. wt. 262.687, 6.5 g, 49.6% yield) precipited. The precipitate was crystallized from water-ethanol (1: 3). It showed a m.p. of 167- 169°C.

Synthesis of 2-(4-chloro-phenoxymethyl)-benzoyl chloride (4)

2-(4-chlorophenoxymethyl)-benzoic acid (1, 5.25 g, 0.02 mol), dry 1,2-dichlorethane (30 mL) and thionyl chloride (mol. wt. 119, d₄²⁰ 1.6385 g/mL, 3 mL, 0.042 mol) were placed in a round-bottomed flask equipped with a condenser and drying tube. The mixture was refluxed for 3 hours. The excess thionyl chloride and the solvent were removed under reduced pressure and the crude acid was used directly in the next step.

General procedure for the synthesis of the new thioureides (5a)-(5h)

To a solution of ammonium thiocyanate (mol. wt. 76.13, 0.76 g, 0.01 mol, dried by heating at 100°C) in dry acetone (5 mL, dried over potassium carbonate) was added a solution of 2-(4-chlorophenoxymethyl)-benzoyl chloride (4, mol. wt. 281.39, 0.01 mol) in dry acetone (15 mL). The reaction mixture was refluxed one hour in a round-bottomed flask equipped with a condenser and a drying tube. After cooling, dry and freshly distilled primary aromatic amine (0.01 mol) in dry acetone (2 mL) were added by stirring, to the reaction mixture. The mixture was then refluxed for one hour. The product was precipitated after the cooled reaction mixture was poured into water (500 mL). The crude thioureides obtained were crystallised from isopropanol containing active carbon.

Microbial strains

The antimicrobial activity of the investigated compounds was tested against bacterial and fungal strains recently isolated from clinical specimens as well as reference strains belonging to the following genera and species: Gram positive (methicillin resistant Staphylococcus aureus, Listeria monocytogenes, Bacillus subtilis), Gram-negative (Escherichia coli, Salmonella enteritidis, Pseudomonas aeruginosa) and Candida albicans. The microbial strains were identified by aid of VITEK I automatic system. VITEK cards for identification and susceptibility testing (GNS-522) were inoculated and incubated according to the manufacturer's recommendations. The results were interpreted by using software version AMS R09.1. Bacterial suspensions of 1.5x10⁸ CFU/mL or 0.5 McFarland density obtained from 15-18 h bacterial cultures developed on solid media were used in the experiments. The antimicrobial activity was tested on Mueller-Hinton medium recommended for the bacterial strains and Yeast Peptone Glucose (YPG) medium for Candida albicans. We used the solutions of the new compounds in DMSO with 2048 μg/ mL concentration. The cell cultures used in cytotoxicity assay were represented by HeLa (ECACC # 93021013) cells. The cells were grown in Dulbecco’s Modified Essential medium DMEM (Sigma) supplemented with 10 % fetal calf serum (Sigma) at 37°C, 5% CO₂, in a humid atmosphere [5,6].

Qualitative screening of the antimicrobial properties of the tested compounds

The qualitative screening was performed by an adapted disk diffusion method. Petri dishes with Mueller Hinton (for bacterial strains)/YPG (for yeasts) media were seeded with bacterial inoculums as for the classical antibiotic susceptibility testing disk diffusion method (Kirby-Bauer); 5 mm diameter paper filter disks were placed on the seeded medium, at 30 mm distance. Subsequently, the disks were impregnated with 5 μL tested compound solution (1024 µg/mL concentration). The plates were left at room temperature for 20-30 minutes and then incubated at 37^oC for 24 hrs. The positive results were read as the occurrence of an inhibition zone of microbial growth around the disk [7,8,9].

Quantitative assay of the antimicrobial activity

These tests were performed by the binary micro dilution method, in 96 multi-well plates, in order to establish the minimal inhibitory concentration (MIC) [10,11,12]. For this purpose, serial binary dilutions of the tested compounds (ranging between 1024 and 16 µg/ mL) were performed in a 200 μL volume of nutrient broth and each well was seeded with 50 μL microbial inoculum. The plates were incubated for 24 hrs at 37^oC, and MICs were read as the lowest concentration of compound which inhibited the microbial growth.

Flow cytometry and annexin V assay

HeLa cells were grown in DMEM supplemented with 10% foetal calf serum (FCS) and 24 h later 5 μg/ml of the tested compound were added. Cells from the supernatant and monolayer were harvested and 1×10⁵ cells were stained with annexin V and propidium iodide using the Immunotech Annexin V-FITC Kit (Beckman Coulter Company, France) following the manufacturer’s instructions. Cells were analyzed by flow cytometry using a Coulter EPICS XL flow cytometer (Beckman Coulter). Green fluorescence (525 nm; FITC annexin V) and red fluorescence (613 nm; propidium iodide) were measured. The experiment was repeated three times [5,6].